19 Patents
- 0 cites
- US124126392025Method of Characterizing a Tumor Based on an Immune Gene Expression Signature in Regulatory T Cell (treg)-enriched Tumor Samples
Nant Holdings IP, LLC
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US120535122024Method of Validating the Triggering of an Immune Response to a Neoepitope of a Tumor with T-cells
Nantomics, LLC
0 cites - 0 cites
- 0 cites
- US117566512023Method of Treating a Tumor in a Patient Based on an Immune Gene Expression
Nant Holdings IP, LLC
0 cites - US117175642023Iterative Discovery of Neoepitopes and Adaptive Immunotherapy and Methods Therefor
Nantomics, LLC
0 cites - 0 cites
- 0 cites
- 0 cites
- US116261872023Systems, Compositions, and Methods for Discovery of MSI and Neoepitopes That Predict Sensitivity to Checkpoint Inhibitors
Nantomics LLC
0 cites